Johnson & Johnson Stock Is Soaring Because Earnings Beat, Raised Guidance

barrons logo

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit

  • Order Reprints

  • Print Article

Pharma giant Johnson & Johnson reported earnings early Tuesday that beat analyst estimates, sending shares soaring.

Johnson & Johnson (ticker: JNJ) reported sales of $23.3 billion for the third quarter, up 10.7% from the same quarter last year. Adjusted earnings were $2.60 per share, up 18.2% from a year ago.

Analysts had expected slightly…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button